EXELIXIS, INC. DEF 14A Filing

Ticker: EXEL · Form: DEF 14A · Filed: Apr 18, 2024 · CIK: 939767

Sentiment: neutral

Topics: DEF 14A, Proxy Statement, Exelixis, Shareholder Meeting, Executive Compensation

TL;DR

<b>Exelixis, Inc. files its Definitive Proxy Statement for the period ending May 30, 2024.</b>

AI Summary

EXELIXIS, INC. (EXEL) filed a Proxy Statement (DEF 14A) with the SEC on April 18, 2024. The filing is a Definitive Proxy Statement (DEF 14A) for Exelixis, Inc. The report is for the period ending May 30, 2024. The company's principal executive offices are located at 1851 Harbor Bay Parkway, Alameda, CA 94502. The fiscal year end for Exelixis, Inc. is December 29. The filing fee is marked as 'No fee required'.

Why It Matters

For investors and stakeholders tracking EXELIXIS, INC., this filing contains several important signals. This DEF 14A filing is crucial for shareholders to understand upcoming corporate decisions and executive compensation details before the annual meeting. The proxy statement provides information on how shareholders can vote on important matters, including the election of directors and executive compensation plans.

Risk Assessment

Risk Level: — EXELIXIS, INC. shows moderate risk based on this filing. The filing is a standard DEF 14A proxy statement, which typically contains routine corporate governance and executive compensation information, posing no immediate unusual risk.

Analyst Insight

Review the executive compensation details and director nominations within the proxy statement to assess alignment with shareholder value creation and company performance.

Key Numbers

Key Players & Entities

FAQ

When did EXELIXIS, INC. file this DEF 14A?

EXELIXIS, INC. filed this Proxy Statement (DEF 14A) with the SEC on April 18, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by EXELIXIS, INC. (EXEL).

Where can I read the original DEF 14A filing from EXELIXIS, INC.?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by EXELIXIS, INC..

What are the key takeaways from EXELIXIS, INC.'s DEF 14A?

EXELIXIS, INC. filed this DEF 14A on April 18, 2024. Key takeaways: The filing is a Definitive Proxy Statement (DEF 14A) for Exelixis, Inc.. The report is for the period ending May 30, 2024.. The company's principal executive offices are located at 1851 Harbor Bay Parkway, Alameda, CA 94502..

Is EXELIXIS, INC. a risky investment based on this filing?

Based on this DEF 14A, EXELIXIS, INC. presents a moderate-risk profile. The filing is a standard DEF 14A proxy statement, which typically contains routine corporate governance and executive compensation information, posing no immediate unusual risk.

What should investors do after reading EXELIXIS, INC.'s DEF 14A?

Review the executive compensation details and director nominations within the proxy statement to assess alignment with shareholder value creation and company performance. The overall sentiment from this filing is neutral.

How does EXELIXIS, INC. compare to its industry peers?

Exelixis, Inc. operates in the biotechnology sector, focusing on the development and commercialization of novel medicines.

Are there regulatory concerns for EXELIXIS, INC.?

The filing is made under the Securities Exchange Act of 1934, specifically Section 14(a), which governs the solicitation of proxies.

Industry Context

Exelixis, Inc. operates in the biotechnology sector, focusing on the development and commercialization of novel medicines.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, specifically Section 14(a), which governs the solicitation of proxies.

What Investors Should Do

  1. Review the proxy statement for details on director nominees and their qualifications.
  2. Analyze the executive compensation structure and any proposed changes.
  3. Understand the proposals to be voted on at the shareholder meeting and the board's recommendations.

Year-Over-Year Comparison

This is the initial DEF 14A filing for the reporting period ending May 30, 2024.

Filing Stats: 4,724 words · 19 min read · ~16 pages · Grade level 11.9 · Accepted 2024-04-18 06:03:27

Key Financial Figures

Filing Documents

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 47 Information about our Executive Officers 50 Compensation of Executive Officers 52 Compensation Discussion and Analysis 52 Executive Summary 52 How We Determine Executive Compensation 57 Compensation Elements 60 Compensation Mix 62 2023 Compensation Decisions 62 Other Compensation Information 72 Compensation Policies and Practices as They Relate to Risk Management 74 Summary of Compensation 75 Grants of Plan-Based Awards 78 Compensation Arrangements 80 Outstanding Equity Awards at Fiscal Year-End 81 Option Exercises and Stock Vested 84 Potential Payments Upon Termination or Change in Control 84 CEO Pay Ratio 88 Pay Versus Performance 89 Compensation Committee Report 94 Compensation Committee Interlocks and Insider Participation 94 Certain Relationships and Related Party Transactions 94 Householding of Proxy Materials 95 Annual Report on Form 10-K 95 Other Matters 95 Appendix A A- 1 Table of Contents i Exelixis, Inc. QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTI NG Why am I receiving these materials? We have made these materials available to you on the Internet or, upon your request, have delivered printed versions of these materials to you by mail because the Board of Directors (the Board), of Exelixis, Inc. (sometimes referred to as "we," "us," the "company" or "Exelixis") is soliciting your proxy to vote at the 2024 Annual Meeting of Stockholders (Annual Meeting), including at any adjournments or postponements of the meeting. The Annual Meeting will be held virtually, on Thursday, May 30, 2024, at 9:00 a.m., Pacific Time, via live webcast at www.virtualshareholdermeeting.com/EXEL2024 . We invite you to attend the Annual Meeting to vote your shares on the proposals described in this Proxy Statement, which will require your 16-digit control number provided on your Notice

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing